| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 22.883 | 67.068 | 48.083 | 216 | 0 | 0 | 0 | - | - |
| Total Income - EUR | 0 | 22.928 | 67.114 | 48.084 | 217 | 1 | 1 | 0 | - | - |
| Total Expenses - EUR | 438 | 33.344 | 66.731 | 46.916 | 1.135 | 0 | 0 | 0 | - | - |
| Gross Profit/Loss - EUR | -438 | -10.416 | 384 | 1.168 | -918 | 1 | 1 | 0 | - | - |
| Net Profit/Loss - EUR | -438 | -10.645 | -287 | 604 | -925 | 1 | 1 | 0 | - | - |
| Employees | 0 | 2 | 3 | 1 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Pharma Co. Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 923 | 960 | 553 | 160 | 0 | 0 | 0 | 0 | - | - |
| Current Assets | 372 | 20.854 | 18.797 | 12.581 | 10.535 | 10.336 | 10.004 | 10.035 | - | - |
| Inventories | 220 | 13.429 | 12.131 | 6.988 | 6.617 | 6.491 | 6.347 | 6.367 | - | - |
| Receivables | 0 | 3.346 | 5.166 | 2.599 | 0 | 0 | 0 | 0 | - | - |
| Cash | 152 | 4.078 | 1.500 | 2.995 | 3.919 | 3.845 | 3.657 | 3.668 | - | - |
| Shareholders Funds | -393 | -11.034 | -11.134 | -10.326 | -11.051 | -10.841 | -10.600 | -10.632 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 1.687 | 32.848 | 30.485 | 23.067 | 21.586 | 21.177 | 20.604 | 20.668 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharma Co. Plus S.r.l.